401 related articles for article (PubMed ID: 8655665)
41. [Color-coded Doppler sonography of primary and secondary liver tumors].
Börner N; Clement T; Herzog P; Kreitner KF; Miltenberger H; Schild H; Meyer J
Ultraschall Med; 1990 Dec; 11(6):274-80. PubMed ID: 1965059
[TBL] [Abstract][Full Text] [Related]
42. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
43. Hepatocellular carcinoma: contrast enhancement with Levovist.
Choi BI; Kim AY; Lee JY; Kim KW; Lee KH; Kim TK; Han JK
J Ultrasound Med; 2002 Jan; 21(1):77-84. PubMed ID: 11794406
[TBL] [Abstract][Full Text] [Related]
44. Ultrasound of focal hepatic lesions.
Nisenbaum HL; Rowling SE
Semin Roentgenol; 1995 Oct; 30(4):324-46. PubMed ID: 8539643
[TBL] [Abstract][Full Text] [Related]
45. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors.
Strobel D; Krodel U; Martus P; Hahn EG; Becker D
J Clin Ultrasound; 2000 Jan; 28(1):1-13. PubMed ID: 10602099
[TBL] [Abstract][Full Text] [Related]
46. Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material-early experience.
Heckemann RA; Cosgrove DO; Blomley MJ; Eckersley RJ; Harvey CJ; Mine Y
Radiology; 2000 Aug; 216(2):592-6. PubMed ID: 10924591
[TBL] [Abstract][Full Text] [Related]
47. Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2004 Feb; 23(2):207-15. PubMed ID: 14992357
[TBL] [Abstract][Full Text] [Related]
48. [Contrast enhanced power Doppler sonography: comparison of various administration forms of the ultrasound contrast agent Levovist].
Kratzer W; Kächele V; Merkle E; Mason RA; Büchner M; von Tirpitz C; Pfeiffer M
Rofo; 2000 May; 172(5):443-8. PubMed ID: 10874971
[TBL] [Abstract][Full Text] [Related]
49. [Intravenous ultrasound contrast agent, Levovist].
Kudo M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():306-13. PubMed ID: 11761963
[No Abstract] [Full Text] [Related]
50. [The tissue characterization of focal liver lesions by color Doppler echography].
De Gaetano AM; Barbaro B; Chiarla C; De Franco A; Maresca G; Marano P
Radiol Med; 1995 Apr; 89(4):453-63. PubMed ID: 7597227
[TBL] [Abstract][Full Text] [Related]
51. Characterization of focal liver lesions in real time using harmonic imaging with high mechanical index and contrast agent levovist.
Migaleddu V; Virgilio G; Turilli D; Conti M; Campisi G; Canu N; Sirigu D; Vincentelli I
AJR Am J Roentgenol; 2004 Jun; 182(6):1505-12. PubMed ID: 15149997
[TBL] [Abstract][Full Text] [Related]
52. [Tissue diagnosis with Doppler ultrasound].
Blank W; Braun B
Bildgebung; 1995 Apr; 62 Suppl 1():31-5. PubMed ID: 7670298
[No Abstract] [Full Text] [Related]
53. [Pulse inversion ultrasonography with ultrasonography contrast media (levovist) in the evaluation of hepatic metastasis].
Giovagnoni A; Martegani A; Aiani L; Ligabue G; Romagnoli R; Del Favero C
Radiol Med; 2001 Mar; 101(3):111-7. PubMed ID: 11402947
[TBL] [Abstract][Full Text] [Related]
54. Solitary hepatic lesions with a hypoechoic rim: value of color Doppler sonography.
von Herbay A; Frieling T; Niederau C; Häussinger D
AJR Am J Roentgenol; 1997 Dec; 169(6):1539-41. PubMed ID: 9393160
[TBL] [Abstract][Full Text] [Related]
55. Dynamic contrast-enhanced power Doppler sonography improves the differential diagnosis of liver lesions.
Strobel D; Hoefer A; Martus P; Hahn EG; Becker D
Int J Colorectal Dis; 2001 Aug; 16(4):247-56. PubMed ID: 11515685
[TBL] [Abstract][Full Text] [Related]
56. [Comparison of contrast harmonic imaging in B-mode with stimulated acoustic emission, conventional B-mode US and spiral CT in the detection of focal liver lesions].
Beissert M; Jenett M; Keberle M; Kessler C; Klein D; Beer M; Hahn D
Rofo; 2000 Apr; 172(4):361-6. PubMed ID: 10961221
[TBL] [Abstract][Full Text] [Related]
57. The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors.
Yamamoto K; Shiraki K; Nakanishi S; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Fuke H; Hashimoto A; Shimizu A; Okuda Y; Nakano T
Int J Oncol; 2003 Feb; 22(2):353-8. PubMed ID: 12527934
[TBL] [Abstract][Full Text] [Related]
58. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report.
Leen E; Angerson WJ; Warren HW; O'Gorman P; Moule B; Carter EC; McArdle CS
Br J Surg; 1994 Feb; 81(2):252-4. PubMed ID: 8156351
[TBL] [Abstract][Full Text] [Related]
59. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
60. Dynamic contrast-enhanced ultrasound with carbon dioxide microbubbles as adjunct to arteriography of liver tumors.
Veltri A; Capello S; Faissola B; Spalluto F; Farinet S; Grosso M
Cardiovasc Intervent Radiol; 1994; 17(3):133-7. PubMed ID: 8087828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
